Feb. 5, 2018 Price forecast | 2 weeks: 2.54% | 1 month: 2.28% | 3 months: 1.21%


PBH stock forecast

Our latest prediction for Prestige Consumer Healthcare, Inc.'s stock price was made on the Feb. 5, 2018 when the stock price was at 35.53$.

In the short term (2weeks), PBH's stock price should outperform the market by 2.54%. During that period the price should oscillate between -5.28% and +9.03%.

In the medium term (3months), PBH's stock price should outperform the market by 1.21%. During that period the price should oscillate between -12.54% and +18.07%.


About Prestige Consumer Healthcare, Inc.

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.

At the moment the company generates 1020M USD in revenues.

On its last earning announcement, the company reported a profit of 6.38$ per share.

The book value per share is 22.46$

Prestige Consumer Healthcare, Inc. website


Three months stock forecastFeb. 5, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
1020M 55.60% 203M 19.89% 340M 6.38 - - 53M 22.46 197M -13M 184M